MetLife's Preferred Stock, Series F Yield Pushes Past 6%

On Thursday, MetLife Inc.'s 4.75% non-cumulative preferred stock (MET.PRF) traded with a yield exceeding 6% and at a notable 20.40% discount to its liquidation preference, significantly wider than the financial preferred stock category's 14.08% average discount. This wider discount, coupled with its non-cumulative dividend feature, presents a key characteristic for income investors evaluating the security, even as its yield trails the broader financial preferred sector average of 6.99%. Both MET.PRF and MetLife common shares experienced slight declines during the day.

Analysis

MetLife Inc.'s 4.75% non-cumulative preferred stock, Series F (MET.PRF), is exhibiting notable valuation and yield characteristics. On Thursday, the security's yield surpassed 6%, based on its $1.1875 annualized dividend, as its price fell to a low of $19.77. This yield, however, trails the 6.99% average for the broader financial preferred stock category. Concurrently, MET.PRF is trading at a significant 20.40% discount to its liquidation preference, a discount substantially wider than the 14.08% average for its peers. This suggests the market is pricing in a higher degree of risk or a lower relative value for this specific issue. A critical factor for consideration is the security's non-cumulative nature, which means any missed dividend payments are not owed to shareholders in the future. The mild price decline of approximately 0.7% for MET.PRF and 0.4% for the common stock (MET) during the session aligns with the mildly negative sentiment signals.

Key Decisions for Investors

• Investors should weigh the potential for capital appreciation from the significant 20.40% discount to liquidation value against the security's lower-than-average yield and its non-cumulative dividend structure, which elevates the risk of income loss.
• For income-focused portfolios, a relative value analysis is crucial, as the financial sector average yield is nearly a full percentage point higher at 6.99%, potentially offering better compensation for risk elsewhere.
• Given the non-cumulative feature, closely monitor MetLife's underlying credit health and dividend coverage, as any suspension of payments would result in a permanent loss of income for shareholders.
• The combination of a wide discount and a below-average yield may signal market concerns, warranting caution for those considering new positions until the reasons for this valuation gap are clearer.